Cited by

• Deletion mapping of gliomas suggest the presence of two small regions for candidate tumor-suppressor genes in a 17-cM interval on chromosome 10q.

  Albarosa R, Colombo BM, Roz L, Magnani I, Pollo B, Cirenei N, Giani C, Conti AM, DiDonato S, Finocchiaro G. Albarosa R, et al. Am J Hum Genet. 1996 Jun;58(6):1260-7. Am J Hum Genet. 1996. PMID: 8651304 Free PMC article.
• Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma.

  Agarwal A, Polineni R, Hussein Z, Vigoda I, Bhagat TD, Bhattacharyya S, Maitra A, Verma A. Agarwal A, et al. Int J Clin Exp Pathol. 2012;5(5):382-96. Epub 2012 May 23. Int J Clin Exp Pathol. 2012. PMID: 22808291 Free PMC article. Review.
• Self-destruction and tolerance in resistance of mammalian cells to alkylation damage.

  Karran P, Bignami M. Karran P, et al. Nucleic Acids Res. 1992 Jun 25;20(12):2933-40. doi: 10.1093/nar/20.12.2933. Nucleic Acids Res. 1992. PMID: 1620587 Free PMC article. Review. No abstract available.
• Variant allelic frequencies of driver mutations can identify gliomas with potentially false-negative MGMT promoter methylation results.

  McCord M, Jamshidi P, Thirunavu V, Santana-Santos L, Vormittag-Nocito E, Dittman D, Parker S, Baczkowski J, Jennings L, Walshon J, McCortney K, Galbraith K, Zhang H, Lukas RV, Stupp R, Dixit K, Kumthekar P, Heimberger AB, Snuderl M, Horbinski C. McCord M, et al. Acta Neuropathol Commun. 2023 Nov 2;11(1):175. doi: 10.1186/s40478-023-01680-0. Acta Neuropathol Commun. 2023. PMID: 37919784 Free PMC article.